PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22842585-9	2012	In contrast, rosiglitazone pretreatment led to greater increases in striatal GFAP expression than 6-OHDA alone and changes in the expression of this protein preceded the changes that were seen with TH expression.	Rosiglitazone	13-26	glial fibrillary acidic protein	Rattus norvegicus	77-81	
33417950-8	2021	CONCLUSIONS: Combined semaglutide with RSG exhibited synergistically protective efficacies on retinal cells by decreasing the GFAP expression, inhibiting oxidative stress and PI3K/Akt/MTOR signaling-transduction in DR model rats.	Rosiglitazone	39-42	glial fibrillary acidic protein	Rattus norvegicus	126-130	
25022803-13	2014	CONCLUSION: Rosiglitazone reduced SAH mortality, neurological deficits, body weight loss, GFAP loss, and cerebral vasospasm by preventing the neurotoxicity induced by glutamate and oxidative stress.	Rosiglitazone	12-25	glial fibrillary acidic protein	Rattus norvegicus	90-94